Article ; Online: Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes.
International journal of nanomedicine
2023 Volume 18, Page(s) 4403–4419
Abstract: Background: The activation of lymphatic vessel function is the crux to resolving atherosclerosis (AS), a chronic inflammatory disease. Rapamycin (RAPA) recently has attracted considerable attention as a potent drug to induce atherosclerotic plaque ... ...
Abstract | Background: The activation of lymphatic vessel function is the crux to resolving atherosclerosis (AS), a chronic inflammatory disease. Rapamycin (RAPA) recently has attracted considerable attention as a potent drug to induce atherosclerotic plaque attenuation. The objective of this work was to develop a ligand-decorated, RAPA-loaded liposome for lymphatic-targeted delivery of drugs to improve abnormal lymphatic structure and function, resulting in highly effective regression of atherosclerotic plaques. Methods: Hyaluronic acid-decorated, RAPA-loaded liposomes (HA-RL) were fabricated by emulsion-solvent evaporation. The average size, zeta potential, entrapment efficiency were characterized, and the stability and drug release in vitro were investigated. Furthermore, the in vitro and in vivo lymphatic targeting ability were evaluated on lymphatic endothelial cells and LDLR Results: HA-RL had a size of 100 nm, over 90% drug encapsulation efficiency, the storage stability was distinguished, demonstrating a slow release from the lipid nano-carriers. The mean retention time (MRT) and elimination half-life (t Conclusion: HA-RL exhibited the most appreciable lymphatic targeting ability and best atherosclerotic plaques attenuation efficiency, opening a new paradigm and promising perspective for the treatment of arteriosclerosis. |
---|---|
MeSH term(s) | Mice ; Animals ; Liposomes/chemistry ; Hyaluronic Acid/chemistry ; Sirolimus/pharmacology ; Plaque, Atherosclerotic/drug therapy ; Endothelial Cells ; Drug Delivery Systems/methods ; Atherosclerosis/drug therapy |
Chemical Substances | Liposomes ; Hyaluronic Acid (9004-61-9) ; Sirolimus (W36ZG6FT64) |
Language | English |
Publishing date | 2023-08-02 |
Publishing country | New Zealand |
Document type | Journal Article |
ZDB-ID | 2364941-0 |
ISSN | 1178-2013 ; 1176-9114 |
ISSN (online) | 1178-2013 |
ISSN | 1176-9114 |
DOI | 10.2147/IJN.S410653 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6606: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.